Benign Prostatic Hyperplasia
📧 Sign up to get email alerts when something new happens for Benign Prostatic Hyperplasia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-02-26Clinical Trial Update: Evaluation of the Potential Association Between 5α-reductase Inhibitors Prescription and Occurrence of High Grade Prostate Cancers
A completed clinical trial evaluated whether prescription of 5-alpha-reductase inhibitors is associated with higher-grade prostate cancers i…
-
FDA approval · 2018-02-13FDA Approved: DOXAZOSIN — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved an original application for doxazosin (generic), manufactured by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.,…
-
CLINICAL_TRIALS research · 2018-02-05Clinical Trial Update: 5 Alpha Reductase Inhibitors And The Risk Of Suicide And Depression
A completed clinical trial evaluating the risk of suicide and depression with 5-alpha-reductase inhibitors in cases related to benign prosta…
-
CLINICAL_TRIALS trial_result · 2017-11-24Clinical Trial Update: Pharmacokinetics and Safety/Tolerability of YY-201 in Comparison to Dutasteride and Tadalafil [Phase 1]
Phase 1 trial update reports pharmacokinetics and safety/tolerability of YY-201 compared with dutasteride and tadalafil in men with benign p…
-
FDA approval · 2017-11-21FDA Approved: DUTASTERIDE — Original Application (Epic Pharma, LLC)
FDA approved the original application for dutasteride by Epic Pharma, LLC, enabling a generic version of dutasteride to be marketed in the U…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: AQUABEAM India Study for the Treatment of Benign Prostatic Hyperplasia [NA]
The AQUABEAM India study evaluating the Aquablation system for benign prostatic hyperplasia has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia [NA]
This completed clinical trial update reports on acute hemostasis after using the AQUABEAM System to treat benign prostatic hyperplasia.
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia II [NA]
A completed clinical trial evaluating acute hemostasis after using the AQUABEAM System for treating benign prostatic hyperplasia.
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: KTP Green Light Prostatectomy Compared With Open Prostatectomy [Phase 4]
This update reports the completion of a Phase 4 trial comparing KTP Green Light prostatectomy with open prostatectomy for benign prostatic h…
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: KTP (Potassium-titanyl-phosphate) Laser Versus TUR-P (Transurethral Resection of Prostate) [NA]
A clinical trial comparing potassium-titanyl-phosphate laser to transurethral resection of the prostate for benign prostatic hyperplasia has…
-
FDA approval · 2017-11-01FDA Approved: JALYN — Supplemental Application (Waylis Therapeutics)
The FDA approved a supplemental application for JALYN (dutasteride and tamsulosin hydrochloride) submitted by Waylis Therapeutics.
-
CLINICAL_TRIALS withdrawal · 2017-10-30Clinical Trial Update: On Label, Randomized, Double-Blind, Placebo-Controlled Trial of Preoperative Finasteride in Patients Undergoing Transurethral Resection of the Prostate (TURP) [Phase 3]
This Phase 3 randomized, double-blind, placebo-controlled trial of preoperative finasteride in men undergoing TURP for benign prostatic hype…
-
CLINICAL_TRIALS trial_result · 2017-10-26Clinical Trial Update: TRT on BPH Hypoganadal MetS Patients. Florence-PROTEST [Phase 4]
Phase 4 clinical trial update shows completion of a study evaluating testosterone replacement therapy in men with benign prostatic hyperplas…
-
CLINICAL_TRIALS withdrawal · 2017-10-17Clinical Trial Update: Prostate Artery Embolization for the Treatment of Benign Prostatic Hyperplasia [NA]
A clinical trial evaluating Prostate Artery Embolization for benign prostatic hyperplasia (NCT03179228) has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-10-16Clinical Trial Update: Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS
An observational study of dutasteride (Avodart) in men with benign prostatic hyperplasia (the OASIS trial) has completed.
-
FDA approval · 2017-09-29FDA Approved: DOXAZOSIN — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves Teva's supplemental application for doxazosin (doxazosin mesylate) under ANDA075536.
-
CLINICAL_TRIALS trial_result · 2017-08-23Clinical Trial Update: A-botulinic Toxin for Symptomatic Benign Prostate Hypertrophy [Phase 3]
Phase 3 study evaluating A-botulinic Toxin for symptomatic benign prostatic hyperplasia, sponsored by University Hospital, Bordeaux, has com…
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: A Study To Compare Giving AVODART And FLOMAX Together Or In A Combination Capsule In The Fed And Fasted State [Phase 1]
A Phase 1 trial update comparing co-administration of AVODART (dutasteride) and FLOMAX (tamsulosin) either together or in a combination caps…
-
CLINICAL_TRIALS trial_result · 2017-08-11Clinical Trial Update: Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia Patients [Phase 3]
A Phase 3 trial evaluating CKD-397 for efficacy and safety in benign prostatic hyperplasia has completed; the update does not disclose trial…
-
FDA approval · 2017-08-11FDA Approved: TAMSULOSIN HYDROCHLORIDE — Original Application (Ascend Laboratories, LLC)
FDA approved Ascend Laboratories' generic tamsulosin hydrochloride via an original ANDA for the treatment of benign prostatic hyperplasia.
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: A Clinical Trial to Evaluate the Effects of Food on the Bioavailability of CKD-397 in Healthy Male Subjects [Phase 1]
Phase 1 study evaluating the effect of food on the bioavailability of CKD-397 in healthy male volunteers.
-
CLINICAL_TRIALS trial_result · 2017-08-04Clinical Trial Update: A Study To Compare 3 Different Formulations Of Tamsulosin At Steady State. [Phase 1]
Phase 1 study comparing three formulations of tamsulosin at steady state has completed in benign prostatic hyperplasia. The sponsor is Glaxo…
-
CLINICAL_TRIALS trial_result · 2017-07-28Clinical Trial Update: ThuLEP vs. HoLEP vs. Monopolar Enucleation in Management of BPH [NA]
A completed clinical trial comparing ThuLEP, HoLEP, and monopolar enucleation techniques for the management of benign prostatic hyperplasia.
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Prostate Embolization for Acute Urinary Retention Study [NA]
This clinical trial update covers prostate embolization for acute urinary retention in men with benign prostatic hyperplasia. The status of …
-
CLINICAL_TRIALS trial_result · 2017-07-14Clinical Trial Update: Prospective Sexual Function Study for BPH Subjects [Phase 4]
Phase 4 trial updating prospective sexual function in men with benign prostatic hyperplasia has completed with results posted.